Ultragenyx Pharmaceutical Inc. - Company Profile and SWOT Analysis
Ultragenyx Pharmaceutical Inc. %li%Company Profile and SWOT Analysis
Summary
Ultragenyx Pharmaceutical Inc. %li%Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Ultragenyx Pharmaceutical Inc. (Ultragenyx or ‘the company’) is a clinical-stage biopharmaceutical company. It is involved in the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare diseases. The company’s marketed products include Crysvita for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO); Mepsevii for treatment of mucopolysaccharidosis VII (MPS VII, Sly syndrome); and Dojolvi for treatment of long-chain fatty acid oxidation disorders (LC-FAOD). It is also developing two pipeline products including, DTX301 for the treatment of ornithine transcarbamylase (OTC) deficiency; and DTX401 for treatment of glycogen storage disease type 1a (GSDIa). Ultragenyx through its subsidiaries operates in the UK, Switzerland, the US, Germany, Brazil, Argentina, Netherlands, France, Colombia, Canada and Mexico. The company is headquartered in Novato, California, the US.
Scope
Summary
Ultragenyx Pharmaceutical Inc. %li%Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Ultragenyx Pharmaceutical Inc. (Ultragenyx or ‘the company’) is a clinical-stage biopharmaceutical company. It is involved in the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare diseases. The company’s marketed products include Crysvita for X-linked hypophosphatemia (XLH) and tumor-induced osteomalacia (TIO); Mepsevii for treatment of mucopolysaccharidosis VII (MPS VII, Sly syndrome); and Dojolvi for treatment of long-chain fatty acid oxidation disorders (LC-FAOD). It is also developing two pipeline products including, DTX301 for the treatment of ornithine transcarbamylase (OTC) deficiency; and DTX401 for treatment of glycogen storage disease type 1a (GSDIa). Ultragenyx through its subsidiaries operates in the UK, Switzerland, the US, Germany, Brazil, Argentina, Netherlands, France, Colombia, Canada and Mexico. The company is headquartered in Novato, California, the US.
Scope
- Detailed information on Ultragenyx Pharmaceutical Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ultragenyx Pharmaceutical Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Ultragenyx Pharmaceutical Inc. including a breakdown and examination of key business segments
- Intelligence on Ultragenyx Pharmaceutical Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ultragenyx Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Ultragenyx Pharmaceutical Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ultragenyx Pharmaceutical Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Ultragenyx Pharmaceutical Inc.'s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Ultragenyx Pharmaceutical Inc.: Company Overview
Ultragenyx Pharmaceutical Inc.: Overview and Key Facts
Ultragenyx Pharmaceutical Inc.: Overview
Ultragenyx Pharmaceutical Inc.: Key Facts
Ultragenyx Pharmaceutical Inc.: Key Employees
Ultragenyx Pharmaceutical Inc.: Key Employee Biographies
Ultragenyx Pharmaceutical Inc.: Major Products and Services
Ultragenyx Pharmaceutical Inc.: Management Statement
Ultragenyx Pharmaceutical Inc.: Locations and Subsidiaries
Ultragenyx Pharmaceutical Inc.: Key Competitors
Ultragenyx Pharmaceutical Inc.: Company Analysis
Ultragenyx Pharmaceutical Inc.: Business Description
Ultragenyx Pharmaceutical Inc.: SWOT Analysis
Ultragenyx Pharmaceutical Inc.: SWOT Overview
Ultragenyx Pharmaceutical Inc.: Strengths
Ultragenyx Pharmaceutical Inc.: Weaknesses
Ultragenyx Pharmaceutical Inc.: Opportunities
Ultragenyx Pharmaceutical Inc.: Threats
Ultragenyx Pharmaceutical Inc.: Corporate Financial Deals Activity
Ultragenyx Pharmaceutical Inc.: Financial Deals Overview
Ultragenyx Pharmaceutical Inc.: Targets and Partners
Ultragenyx Pharmaceutical Inc.: Top Deals 2020 - 2024YTD*
Ultragenyx Pharmaceutical Inc.: Advisors
Ultragenyx Pharmaceutical Inc.: Top Legal Advisors
Ultragenyx Pharmaceutical Inc.: Top Financial Advisors
Ultragenyx Pharmaceutical Inc.: Mergers and Acquisitions
Ultragenyx Pharmaceutical Inc.: Capital Raising
Ultragenyx Pharmaceutical Inc.: Partnership
Ultragenyx Pharmaceutical Inc.: Divestments
Ultragenyx Pharmaceutical Inc.: Recent Developments
Ultragenyx Pharmaceutical Inc.: News and Events Summary
Ultragenyx Pharmaceutical Inc.: Business Expansion
Ultragenyx Pharmaceutical Inc.: Corporate Governance
Ultragenyx Pharmaceutical Inc.: Corporate Social Responsibility
Ultragenyx Pharmaceutical Inc.: Financial Performance
Ultragenyx Pharmaceutical Inc.: Market Developments
Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events
Ultragenyx Pharmaceutical Inc.: Research & Development
Ultragenyx Pharmaceutical Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
Company Snapshot
Ultragenyx Pharmaceutical Inc.: Company Overview
Ultragenyx Pharmaceutical Inc.: Overview and Key Facts
Ultragenyx Pharmaceutical Inc.: Overview
Ultragenyx Pharmaceutical Inc.: Key Facts
Ultragenyx Pharmaceutical Inc.: Key Employees
Ultragenyx Pharmaceutical Inc.: Key Employee Biographies
Ultragenyx Pharmaceutical Inc.: Major Products and Services
Ultragenyx Pharmaceutical Inc.: Management Statement
Ultragenyx Pharmaceutical Inc.: Locations and Subsidiaries
Ultragenyx Pharmaceutical Inc.: Key Competitors
Ultragenyx Pharmaceutical Inc.: Company Analysis
Ultragenyx Pharmaceutical Inc.: Business Description
Ultragenyx Pharmaceutical Inc.: SWOT Analysis
Ultragenyx Pharmaceutical Inc.: SWOT Overview
Ultragenyx Pharmaceutical Inc.: Strengths
Ultragenyx Pharmaceutical Inc.: Weaknesses
Ultragenyx Pharmaceutical Inc.: Opportunities
Ultragenyx Pharmaceutical Inc.: Threats
Ultragenyx Pharmaceutical Inc.: Corporate Financial Deals Activity
Ultragenyx Pharmaceutical Inc.: Financial Deals Overview
Ultragenyx Pharmaceutical Inc.: Targets and Partners
Ultragenyx Pharmaceutical Inc.: Top Deals 2020 - 2024YTD*
Ultragenyx Pharmaceutical Inc.: Advisors
Ultragenyx Pharmaceutical Inc.: Top Legal Advisors
Ultragenyx Pharmaceutical Inc.: Top Financial Advisors
Ultragenyx Pharmaceutical Inc.: Mergers and Acquisitions
Ultragenyx Pharmaceutical Inc.: Capital Raising
Ultragenyx Pharmaceutical Inc.: Partnership
Ultragenyx Pharmaceutical Inc.: Divestments
Ultragenyx Pharmaceutical Inc.: Recent Developments
Ultragenyx Pharmaceutical Inc.: News and Events Summary
Ultragenyx Pharmaceutical Inc.: Business Expansion
Ultragenyx Pharmaceutical Inc.: Corporate Governance
Ultragenyx Pharmaceutical Inc.: Corporate Social Responsibility
Ultragenyx Pharmaceutical Inc.: Financial Performance
Ultragenyx Pharmaceutical Inc.: Market Developments
Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events
Ultragenyx Pharmaceutical Inc.: Research & Development
Ultragenyx Pharmaceutical Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
LIST OF TABLES
Table 1: Ultragenyx Pharmaceutical Inc.: Key Facts
Table 2: Ultragenyx Pharmaceutical Inc.: Key Employees
Table 3: Ultragenyx Pharmaceutical Inc.: Locations and Subsidiaries
Table 4: Ultragenyx Pharmaceutical Inc.: Key Competitors
Table 5: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Table 7: Ultragenyx Pharmaceutical Inc.: Targets and Partners
Table 8: Ultragenyx Pharmaceutical Inc.: Top Deals 2020 - 2024YTD*
Table 9: Ultragenyx Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Ultragenyx Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2020 - YTD*2024)
Table 12: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2020 - YTD*2024)
Table 13: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
Table 14: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
Table 15: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
Table 16: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
Table 17: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
Table 18: Ultragenyx Pharmaceutical Inc.: News and Events Summary
Table 19: Ultragenyx Pharmaceutical Inc.: Business Expansion
Table 20: Ultragenyx Pharmaceutical Inc.: Corporate Governance
Table 21: Ultragenyx Pharmaceutical Inc.: Corporate Social Responsibility
Table 22: Ultragenyx Pharmaceutical Inc.: Financial Performance
Table 23: Ultragenyx Pharmaceutical Inc.: Market Developments
Table 24: Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events
Table 25: Ultragenyx Pharmaceutical Inc.: Research & Development
Table 26: Ultragenyx Pharmaceutical Inc.: Strategy and Operations
Table 1: Ultragenyx Pharmaceutical Inc.: Key Facts
Table 2: Ultragenyx Pharmaceutical Inc.: Key Employees
Table 3: Ultragenyx Pharmaceutical Inc.: Locations and Subsidiaries
Table 4: Ultragenyx Pharmaceutical Inc.: Key Competitors
Table 5: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Table 7: Ultragenyx Pharmaceutical Inc.: Targets and Partners
Table 8: Ultragenyx Pharmaceutical Inc.: Top Deals 2020 - 2024YTD*
Table 9: Ultragenyx Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Ultragenyx Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2020 - YTD*2024)
Table 12: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2020 - YTD*2024)
Table 13: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
Table 14: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
Table 15: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
Table 16: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
Table 17: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
Table 18: Ultragenyx Pharmaceutical Inc.: News and Events Summary
Table 19: Ultragenyx Pharmaceutical Inc.: Business Expansion
Table 20: Ultragenyx Pharmaceutical Inc.: Corporate Governance
Table 21: Ultragenyx Pharmaceutical Inc.: Corporate Social Responsibility
Table 22: Ultragenyx Pharmaceutical Inc.: Financial Performance
Table 23: Ultragenyx Pharmaceutical Inc.: Market Developments
Table 24: Ultragenyx Pharmaceutical Inc.: Regulatory and Legal Events
Table 25: Ultragenyx Pharmaceutical Inc.: Research & Development
Table 26: Ultragenyx Pharmaceutical Inc.: Strategy and Operations
LIST OF FIGURES
Figure 1: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 3: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2020 - YTD*2024)
Figure 4: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2020 - YTD*2024)
Figure 5: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
Figure 6: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
Figure 7: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
Figure 8: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
Figure 9: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
Figure 1: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ultragenyx Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 3: Ultragenyx Pharmaceutical Inc.: M&A Volume and Value Trend (2020 - YTD*2024)
Figure 4: Ultragenyx Pharmaceutical Inc.: M&A Activity by Geography (2020 - YTD*2024)
Figure 5: Ultragenyx Pharmaceutical Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
Figure 6: Ultragenyx Pharmaceutical Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
Figure 7: Ultragenyx Pharmaceutical Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
Figure 8: Ultragenyx Pharmaceutical Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
Figure 9: Ultragenyx Pharmaceutical Inc.: Divestments Volume and Value Trend (2020 - YTD*2024)
